TELA Bio, Inc. (TELA)
NASDAQ: TELA · IEX Real-Time Price · USD
4.630
0.00 (0.00%)
May 2, 2024, 4:00 PM EDT - Market closed

TELA Bio Revenue

In the year 2023, TELA Bio had annual revenue of $58.45M with 41.13% growth. Revenue in the quarter ending December 31, 2023 was $17.00M with 46.26% year-over-year growth.

Revenue (ttm)
$58.45M
Revenue Growth
+41.13%
P/S Ratio
1.95
Revenue / Employee
$257,502
Employees
227
Market Cap
114.15M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202358.45M17.04M41.13%
Dec 31, 202241.42M11.96M40.58%
Dec 31, 202129.46M11.25M61.77%
Dec 31, 202018.21M2.77M17.91%
Dec 31, 201915.45M7.17M86.68%
Dec 31, 20188.27M4.03M94.91%
Dec 31, 20174.25M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
TruBridge 339.44M
FibroGen 147.75M
CytomX Therapeutics 101.21M
Abeona Therapeutics 3.50M
GlycoMimetics 10.00K
Revenue Rankings